WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

The DDDs are based on the treatment of mild-moderate hypertension.
See comments to C02L concerning the principles for assignment of DDDs for combined preparations.


C09B ACE INHIBITORS, COMBINATIONS

Combinations of ACE inhibitors, statins and acetylsalicylic acid are classified in C10BX.


C09BB ACE inhibitors and calcium channel blockers

Combinations with statins are classified in C10BX.


List of abbreviations

Last updated: 2024-01-26